Sort
78,016 grants matching “breast cancer”
Impact of Stretching on Tumor growth and Metastasis
$856,418Helene Langevin · National Institute Of Dental & Craniofacial Research · ZIA · FY2019 · DE
Novel Targets for Vaccine Therapy
$856,385Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2016 · CA
Renal Therapeutic Angiogenesis Using the Novel Biologic ELP-VEGF
$856,297Gene Leflore Bidwell · Leflore Technologies, Llc · R42 · FY2024 · DK
Cellular Interactions with Thrombospondin
$856,071David D Roberts · Division Of Clinical Sciences - Nci · ZIA · FY2011 · CA
Regulation of CTCF Functions and Target Sites by Cancer/Testis-specific CTCF Like BORIS Factor
$855,918Victor Lobanenkov · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Enhancing the Effectiveness of Community Health Workers to Reduce Cervical Cancer Disparities in African American Women
$855,861Douglas W Billings · Isa Associates, Inc. · R44 · FY2022 · MD
Carle Cancer Center Community Clinical Oncology Program
$855,703Kendrith Martin Rowland · Carle Foundation · U10 · FY2008 · CA
SPORE in Pancreatic Cancer
$855,582Donald J. Buchsbaum · University Of Alabama At Birmingham · P20 · FY2007 · CA
Development of SUPR peptides as PET Imaging Agents for Her2+ Breast Cancer
$855,568Stephen Fiacco · Evorx Technologies, Inc. · R44 · FY2016 · CA
Project 1: Implementing Risk-based Tools that Incorporate Tumor Biology to Optimize Screening and Prevention
$855,531Laura J Esserman · University Of California, San Francisco · P01 · FY2024 · CA
New approaches to targeting cell cycle proteins for cancer treatment
$855,249Piotr Sicinski · Dana-Farber Cancer Inst · R35 · FY2025 · CA
Elucidating the role of thrombosis and inflammation in breast cancer metastasis
$855,233Takeo Fujii · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
BIOMARKER VALIDATION LABORATORIES
$855,137University Of Alabama At Birmingham · U24 · FY2002 · CA
Heterotrimeric G Protein Signaling In Allergic Inflammation
$854,927Kirk Druey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Impact of Vaccination against GM2, GD2 and GD3 on Disease Free Survival in Resect
$854,905Wolfgang W Scholz · Mabvax Therapeutics, Inc. · R44 · FY2012 · CA
Carolina Breast Cancer Study
$854,831Robert C Millikan · Univ Of North Carolina Chapel Hill · P50 · FY2012 · CA
Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion
$854,717Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways
$854,717Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Quantitative Ultrasonic Imaging of the Breast
$854,593William D. O'Brien · University Of Illinois At Urbana-Champaign · R01 · FY2011 · CA
Genetic Epidemiology of Telomere Maintenance and Cancer Etiology
$854,568Sharon A. Savage · Division Of Cancer Epidemiology And Genetics · ZIA · FY2013 · CA
Development of Tumor and Immuno-Metabolism Based Small Molecule Therapeutics for Refractory Breast Cancer
$854,530Vincent Sandanayaka · Nirogyone Therapeutics, Llc · R44 · FY2021 · CA
SHCC MU NCORP
$854,438Thomas Lad · Hektoen Institute For Medical Research · UG1 · FY2017 · CA
Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers
$854,326Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Bio-behavioral Research At The Intersection of Cancer and Aging
$854,225Jeanne Mandelblatt · Georgetown University · R35 · FY2020 · CA
A Stakeholder Informed Randomized Trial of Pretest Video Education vs Standard Genetic Counseling for Cancer Patients: Evaluating the Impact on Patients, Providers and Practices
$854,202Huma Q Rana · Dana-Farber Cancer Inst · R01 · FY2021 · HG